Predictive Factors of Hospital Stay in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion and Instrumentation

被引:56
|
作者
Siemionow, Krzysztof [2 ]
Pelton, Miguel A. [1 ]
Hoskins, Jonathan A. [1 ]
Singh, Kern [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Orthoped Surg, Chicago, IL USA
关键词
MIS TLIF; transforaminal lumbar interbody fusion; lumbar; length of stay; fluids; CONTINUOUS-SUBCUTANEOUS-MORPHINE; PREEMPTIVE ANALGESIA; POSTOPERATIVE PAIN; FLUID BALANCE; SURGERY; HYPOTHERMIA; COMPLICATIONS; TRENDS; SPINE;
D O I
10.1097/BRS.0b013e31825c6688
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. A single-center retrospective study. Objective. To identify predictors of length of stay (LOS) days in patients undergoing 1 level minimally invasive (MIS) transforaminal lumbar interbody fusions (TLIF). Summary of Background Data. Recent studies suggest intraoperative fluid administration, and colloid and crystalloid administration among other intraoperative variables may prolong LOS days and increase complications. Therefore, an understanding of which preoperative, intraoperative, and immediate postoperative parameters best predict immediate LOS days will help risk stratify patients and guide decision making. Methods. We retrospectively reviewed 104 patients undergoing a MIS TLIF at 1 institution between 2008 and 2010. Two groups were selected on the basis of the time of discharge. Group 1 consisted of patients discharged within 24 hours after surgery and group 2 consisted of patients discharged more than 24 hours after surgery. Multiple regression analysis was performed to determine which preoperative, intraoperative, and postoperative variables were independent predictors of LOS days. Results. Seventy-eight patients (75%) with a LOS greater than 24 hours had significantly higher estimated blood loss, received more crystalloids, had higher total fluids, longer surgical time, lower end of case temperature, lower hemoglobin during hospitalization, and a lower preoperative narcotic use. Multiple regression analysis showed that significant predictors of increased LOS were postoperative creatinine, visual analogue scale score, intraoperative colloids, fluids input at the end of surgical case, crystalloid to colloid ratio, fluid balance, oxycodone (Oxycontin) use, mean percentage of fraction of inspired oxygen, and preoperative hemoglobin. Conclusion. Patients undergoing 1 level MIS TLIF for degenerative conditions can overall expect a short LOS postoperatively. Multiple preoperative, intraoperative, and immediate postoperative factors can prolong the LOS in this group. This information should help the surgical team in optimizing their intraoperative patient management.
引用
收藏
页码:2046 / 2054
页数:9
相关论文
共 50 条
  • [1] Risk factors for extended hospital stay following minimally invasive transforaminal lumbar interbody fusion
    Anwar, Fatima N.
    Roca, Andrea M.
    Medakkar, Srinath S.
    Loya, Alexandra C.
    Khosla, Ishan
    Singh, Kern
    JOURNAL OF CLINICAL NEUROSCIENCE, 2024, 128
  • [2] Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Ahn, Junyoung
    Tabaraee, Ehsan
    Singh, Kern
    JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2015, 28 (06): : 222 - 225
  • [3] Minimally invasive transforaminal lumbar interbody fusion
    Hoffmann, Christoph-Heinrich
    Kandziora, Frank
    OPERATIVE ORTHOPADIE UND TRAUMATOLOGIE, 2020, 32 (03): : 180 - 191
  • [4] Minimally invasive microendoscopy-assisted transforaminal lumbar interbody fusion with instrumentation
    Isaacs, RE
    Podichetty, VK
    Santiago, P
    Sandhu, FA
    Spears, J
    Kelly, K
    Rice, L
    Fessler, RG
    JOURNAL OF NEUROSURGERY-SPINE, 2005, 3 (02) : 98 - 105
  • [5] Minimally Invasive Transforaminal Lumbar Interbody Fusion and Lateral Interbody Fusion
    Stadler, James A., III
    Dandaleh, Nader S.
    Smith, Zachary A.
    Koski, Tyler R.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2014, 25 (02) : 377 - +
  • [6] Comparison of minimally invasive transforaminal lumbar interbody fusion and midline lumbar interbody fusion in patients with spondylolisthesis
    Wang, Yang-Yi
    Chung, Yu-Hsuan
    Huang, Chun-Hsien
    Hu, Ming-Hsien
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01)
  • [7] Minimally invasive transforaminal lumbar interbody fusion for lumbar spondylolisthesis
    Elboghdady, Islam M.
    Naqvi, Abbas
    Jorgenson, Anton Y.
    Marquez-Lara, Alejandro
    Singh, Kern
    ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (10)
  • [8] Minimally invasive transforaminal lumbar interbody fusion and spondylolisthesis
    Tsahtsarlis, Antonio
    Wood, Martin
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (06) : 858 - 861
  • [9] Minimum Clinically Important Difference in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion
    Nie, James W.
    Hartman, Timothy J.
    MacGregor, Keith R.
    Oyetayo, Omolabake O.
    Zheng, Eileen
    Singh, Kern
    NEUROSURGERY, 2023, 92 (06) : 1199 - 1207
  • [10] Minimally Invasive Transforaminal Lumbar Interbody Fusion (TLIF)
    Badlani, Neil
    Yu, Elizabeth
    Kreitz, Tyler
    Khan, Safdar
    Kurd, Mark F.
    CLINICAL SPINE SURGERY, 2020, 33 (02): : 62 - 64